Literature DB >> 19454473

Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

B Escudier1, V Kataja.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19454473     DOI: 10.1093/annonc/mdp137

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview.

Authors:  Robert J Motzer
Journal:  Oncologist       Date:  2011

Review 2.  Combination therapy for renal cell cancer: what are possible options?

Authors:  Napoleon Santos; Justin B Wenger; Pamela Havre; Yanxia Liu; Roi Dagan; Iman Imanirad; Alison M Ivey; Robert A Zlotecki; Chester B Algood; Scott M Gilbert; Carmen J Allegra; Paul Okunieff; Johannes Vieweg; Nam H Dang; Hendrik Luesch; Long H Dang
Journal:  Oncology       Date:  2011-11-12       Impact factor: 2.935

3.  Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis.

Authors:  Cong Wang; Chong Yu; Fang Yang; Guang Yang
Journal:  Tumour Biol       Date:  2014-07

4.  Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib.

Authors:  Chris Coppin
Journal:  Biologics       Date:  2010-05-25

5.  Simultaneous renal clear cell carcinoma and gastrointestinal stromal tumor in one case.

Authors:  Jin Wen; Han-Zhong Li; Zhi Gang Ji; Wei Gang-Yan; Bing Bing Shi
Journal:  Urol Ann       Date:  2013-04

6.  Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.

Authors:  Jie Mei; Kehan Hu; Xiafeng Peng; Huiyu Wang; Chaoying Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.

Authors:  Tangliang Zhao; Yi Bao; Xinxin Gan; Jie Wang; Qiong Chen; Zhihui Dai; Bing Liu; Anbang Wang; Shuhan Sun; Fu Yang; Linhui Wang
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

8.  Axitinib Induced Recurrent Pneumothorax following Near-Complete Response of Renal Cell Carcinoma Lung Metastasis: An Unexpected Complication.

Authors:  Francisco Socola; Arturo Loaiza-Bonilla; Pasquale Benedetto
Journal:  Case Rep Oncol Med       Date:  2012-12-26

9.  Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.

Authors:  S De Groot; S Sleijfer; W K Redekop; E Oosterwijk; J B A G Haanen; L A L M Kiemeney; C A Uyl-de Groot
Journal:  BMC Cancer       Date:  2016-06-11       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.